The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Khan, Mohammad Farid, Dr.
    Scientist born in November 1970
    Individual (15 offsprings)
    Officer
    2012-01-05 ~ now
    OF - Director → CIF 0
    Dr. Mohammad Farid Khan
    Born in November 1970
    Individual (15 offsprings)
    Person with significant control
    2019-07-19 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 2
    Doig, Andrew James, Professor
    Scientist born in November 1966
    Individual (1 offspring)
    Officer
    2012-01-05 ~ now
    OF - Director → CIF 0
Ceased 7
  • 1
    Bashir, Nazir Bhatt, Dr
    Ned-Commercial born in January 1968
    Individual (5 offsprings)
    Officer
    2021-03-31 ~ 2024-11-01
    OF - Director → CIF 0
  • 2
    Gustafson, Mark Garland, Mr.
    Finance Director born in November 1959
    Individual (1 offspring)
    Officer
    2022-01-25 ~ 2024-07-31
    OF - Director → CIF 0
  • 3
    Dr Mohammed Farid Kahn
    Born in November 1966
    Individual (15 offsprings)
    Person with significant control
    2016-04-06 ~ 2019-07-19
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 4
    Travers, Anthony Geoffrey
    Chief Business Officer born in October 1959
    Individual (2 offsprings)
    Officer
    2013-12-02 ~ 2017-11-02
    OF - Director → CIF 0
  • 5
    Kahn, Elisa Lauren
    Ned- Communications born in August 1963
    Individual (3 offsprings)
    Officer
    2021-03-31 ~ 2021-09-07
    OF - Director → CIF 0
  • 6
    Smith, Ian Geoffrey, Dr
    Chair Person born in September 1948
    Individual (4 offsprings)
    Officer
    2021-04-12 ~ 2021-12-01
    OF - Director → CIF 0
  • 7
    Professor Andrew James Doig
    Born in November 1966
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ 2019-07-19
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

PHARMAKURE LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
2,170,020 GBP2024-01-31
2,170,020 GBP2023-01-31
Property, Plant & Equipment
14,323 GBP2024-01-31
16,800 GBP2023-01-31
Fixed Assets
2,184,343 GBP2024-01-31
2,186,820 GBP2023-01-31
Debtors
83,896 GBP2024-01-31
260,344 GBP2023-01-31
Cash at bank and in hand
44,617 GBP2024-01-31
297,638 GBP2023-01-31
Current Assets
128,513 GBP2024-01-31
557,982 GBP2023-01-31
Creditors
Current, Amounts falling due within one year
-33,983 GBP2024-01-31
-95,463 GBP2023-01-31
Net Current Assets/Liabilities
94,530 GBP2024-01-31
462,519 GBP2023-01-31
Total Assets Less Current Liabilities
2,278,873 GBP2024-01-31
2,649,339 GBP2023-01-31
Creditors
Non-current, Amounts falling due after one year
-4,649,608 GBP2024-01-31
-4,343,286 GBP2023-01-31
Net Assets/Liabilities
-2,370,735 GBP2024-01-31
-1,693,947 GBP2023-01-31
Equity
Called up share capital
338 GBP2024-01-31
338 GBP2023-01-31
Share premium
458,586 GBP2024-01-31
458,586 GBP2023-01-31
Retained earnings (accumulated losses)
-2,829,659 GBP2024-01-31
-2,152,871 GBP2023-01-31
Equity
-2,370,735 GBP2024-01-31
-1,693,947 GBP2023-01-31
Average Number of Employees
32023-02-01 ~ 2024-01-31
32022-02-01 ~ 2023-01-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
19,250 GBP2024-01-31
17,750 GBP2023-01-31
Computers
861 GBP2024-01-31
861 GBP2023-01-31
Property, Plant & Equipment - Gross Cost
20,111 GBP2024-01-31
18,611 GBP2023-01-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
5,488 GBP2024-01-31
1,683 GBP2023-01-31
Computers
300 GBP2024-01-31
128 GBP2023-01-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
5,788 GBP2024-01-31
1,811 GBP2023-01-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
3,805 GBP2023-02-01 ~ 2024-01-31
Computers
172 GBP2023-02-01 ~ 2024-01-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
3,977 GBP2023-02-01 ~ 2024-01-31
Property, Plant & Equipment
Plant and equipment
13,762 GBP2024-01-31
16,067 GBP2023-01-31
Computers
561 GBP2024-01-31
733 GBP2023-01-31
Amount of corporation tax that is recoverable
Current
72,347 GBP2024-01-31
219,762 GBP2023-01-31
Other Debtors
Amounts falling due within one year
11,549 GBP2024-01-31
40,582 GBP2023-01-31
Debtors
Current, Amounts falling due within one year
83,896 GBP2024-01-31
260,344 GBP2023-01-31
Trade Creditors/Trade Payables
Current
13,181 GBP2024-01-31
80,974 GBP2023-01-31
Other Taxation & Social Security Payable
Current
2,774 GBP2024-01-31
0 GBP2023-01-31
Other Creditors
Current
18,028 GBP2024-01-31
14,489 GBP2023-01-31
Creditors
Current
33,983 GBP2024-01-31
95,463 GBP2023-01-31
  • PHARMAKURE LIMITED
    Info
    Registered number 07898244
    Stamford House, Northenden Road, Sale, Cheshire M33 2DH
    Private Limited Company incorporated on 2012-01-05 (13 years 6 months). The company status is In Administration.
    The last date of confirmation statement was made at 2025-01-09
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.